Listen Now—Science Will Win Season 2 Takes on Breast Cancer
Science Will Win, one of Pfizer’s premiere podcasts, is back! This season we’ll explore the advancements and the challenges of cancer treatments, particularly in the breast cancer space. In this special two-part series, we’re looking at how the increasingly innovative medications used to treat cancer come to be.
Part one: Breast Cancer: The Science, The Challenges, The Solutions
Get a better sense of what breast cancer is and dive into some of the early-stage research underway to find new potential therapies.
Part two: Clinical Trials: Bringing Research to Life
We’ll break down a vital piece of how breast cancer treatments come to be: clinical trials. Learn how clinical trials work, how researchers determine that potential new medications are safe and effective, how participants enroll in trials, and why all this work is so important.
Hosted by Adam Rutherford—geneticist, writer, broadcaster and lecturer at University College London—Science Will Win features insights from doctors, researchers, advocates, and patients. Get an inside look at some of the new potential approaches being researched. It’s a groundbreaking time for cancer research, with as many promising possibilities as there are challenges to overcome.
Tune in to this new, two-part series, launching October 27, 2022, on your favorite podcast app
And please don’t forget to subscribe, rate, and review, Science Will Win.
11.23.2022 COVID-19, Medicines Pfizer Signs Agreement to Provide the European Union with PAXLOVID™ 11.16.2022 COVID-19, Research, Vaccines Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection 11.15.2022 Maternal Immunization, Pediatrics, Research, Vaccines Listen Now—The Antigen Season 3 Explores Maternal Immunization 11.03.2022 COVID-19, Research, Vaccines Pfizer and BioNTech Initiate Phase 1 Study of Single Dose mRNA-Based Combination Vaccine Candidate for Influenza and COVID-19 10.31.2022 COVID-19, Health Equity, Partnerships, Vaccines Amid COVID-19 Global Pandemic, The Pfizer Foundation Helps IRC Pursue Urgent Expansion of Health Access in Humanitarian Settings